Plasma and Serum Levels of Tissue Inhibitor of Metalloproteinases-1 Are Associated with Prognosis in Node-negative Breast Cancer

This publication has 18 references indexed in Scilit:

• Gelatinases and their tissue inhibitors in ovarian tumors; TIMP-1 is a predictive as well as a prognostic factor
  Gynecologic Oncology, 2005
• Blood sampling as critical preanalytical determinant to use circulating MMP and TIMP as surrogate markers for pathological processes
  International Journal of Cancer, 2005
• High preoperative serum TIMP-1 is a prognostic indicator for survival in breast carcinoma
  Breast Cancer Research and Treatment, 2005
• Tumor Tissue Levels of Tissue Inhibitor of Metalloproteinase-1 as a Prognostic Marker in Primary Breast Cancer
  Clinical Cancer Research, 2004
• Tissue Inhibitor of Metalloproteinase-1 Protects Human Breast Epithelial Cells Against Intrinsic Apoptotic Cell Death via the Focal Adhesion Kinase/Phosphatidylinositol 3-Kinase and MAPK Signaling Pathway
  Journal of Biological Chemistry, 2003
• Tumor Tissue Concentrations of the Proteinase Inhibitors Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) and Plasminogen Activator Inhibitor Type 1 (PAI-1) Are Complementary in Determining Prognosis in Primary Breast Cancer
  Molecular & Cellular Proteomics, 2003
• Levels of tissue inhibitor of metalloproteinases-1 in blood transfusion components
  Scandinavian Journal of Clinical and Laboratory Investigation, 2002
• Do we need better prognostic factors in node-negative breast cancer?
  European Journal Of Cancer, 2000
• In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1.
  Journal of Clinical Investigation, 1998
• Growth‐promoting activity of tissue inhibitor of metalloproteinases‐1 (TIMP‐1) for a wide range of cells A possible new growth factor in serum
  FEBS Letters, 1992